Biotechnology firm Metsera, renowned for its advancements in medical technologies and innovative pharmaceuticals, has made a successful debut on one of the world’s major stock exchanges, the Nasdaq Global Select Market. This event marks a significant milestone in biotech financing, attracting the interest of investors and analysts alike.